Science Reference

Rofecoxib

Rofecoxib is a nonsteroidal anti-inflammatory drug that was used in the treatment of osteoarthritis, acute pain conditions, and dysmenorrhoea.

Formerly marketed by Merck & Co.

under the trade names Vioxx, Ceoxx and Ceeoxx, it was voluntarily withdrawn from the market in 2004 because of concerns about increased risk of heart attack and stroke..

For more information about the topic Rofecoxib, read the full article at Wikipedia.org, or see the following related articles:

Note: This page refers to an article that is licensed under the GNU Free Documentation License. It uses material from the article Rofecoxib at Wikipedia.org. See the Wikipedia copyright page for more details.

Search ScienceDaily

Number of stories in archives: 44,032

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily's archives for related news topics,
the latest news stories, reference articles, science videos, images, and books.
 

Science Video News


Stopping Strokes

To prevent strokes in at-risk patients who suffer from atrial fibrillation, an abnormal heart rhythm, researchers have devised a mechanical. ...  > full story

Breaking News

... from NewsDaily.com

In Other News ...

Copyright Reuters 2008. See Restrictions.

Free Subscriptions

... from ScienceDaily

Get the latest science news with our free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Feedback

... we want to hear from you!

Tell us what you think of the new ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Post this page to your favorite social bookmarking site:
close
Include this item in your blog or web site:
close
Email this page's link to a friend or colleague:
close